tiprankstipranks
LUCD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsLUCD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
18d ago
Lucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
Premium
The Fly
Lucid Diagnostics granted patent underlying its EsoGuard Esophageal DNA Ttest
1M ago
Castle Biosciences price target raised to $40 from $35 at BTIG
Premium
The Fly
Castle Biosciences price target raised to $40 from $35 at BTIG
1M ago
Lucid Diagnostics Unveils Key Unfiled Financial Snapshot
PremiumCompany AnnouncementsLucid Diagnostics Unveils Key Unfiled Financial Snapshot
4M ago
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
Premium
The Fly
Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
4M ago
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
Premium
The Fly
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
4M ago
Lucid Diagnostics reports Q1 non-GAAP EPS (21c), consensus (27c)
PremiumThe FlyLucid Diagnostics reports Q1 non-GAAP EPS (21c), consensus (27c)
7M ago
Lucid SOS esophageal cell collection device subject to Class II FDA recall
Premium
The Fly
Lucid SOS esophageal cell collection device subject to Class II FDA recall
7M ago
Lucid Diagnostics Raises $11.6M Through Preferred Stock Sale
Premium
Company Announcements
Lucid Diagnostics Raises $11.6M Through Preferred Stock Sale
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100